We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

153 hedge funds and large institutions have $2.22B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 63 increasing their positions, 35 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

254% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 13

85% more capital invested

Capital invested by funds: $1.2B → $2.22B (+$1.02B)

80% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 35

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

25% more funds holding

Funds holding: 122 → 153 (+31)

25% more call options, than puts

Call options by funds: $62.3M | Put options by funds: $49.8M

Holders
153
Holders Change
+31
Holders Change %
+25.41%
% of All Funds
3.01%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.12%
New
46
Increased
63
Reduced
35
Closed
13
Calls
$62.3M
Puts
$49.8M
Net Calls
+$12.5M
Net Calls Change
+$15.9M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$74.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$57.8M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$36M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$36M
5
ACA
Avoro Capital Advisors
New York
+$23.8M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$126M
2
NLVP
New Leaf Venture Partners
New York
-$47M
3
O
OrbiMed
New York
-$45M
4
BI
BVF Inc
California
-$24.1M
5
Alkeon Capital Management
Alkeon Capital Management
New York
-$20.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$5.08M +$2.08M +43,734 +116%
CSS
52
Cubist Systematic Strategies
Connecticut
$5.04M +$3.79M +79,751 +6,646%
Jennison Associates
53
Jennison Associates
New York
$4.45M +$3.4M +71,560 New
TCM
54
Tekla Capital Management
Massachusetts
$3.82M +$2.92M +61,370 New
BCM
55
Burrage Capital Management
Massachusetts
$3.72M +$2.84M +59,818 New
EI
56
EAM Investors
California
$3.63M +$2.78M +58,404 New
Millennium Management
57
Millennium Management
New York
$3.5M -$126M -2,641,505 -98%
Allianz Asset Management
58
Allianz Asset Management
Germany
$3.34M +$1.8M +37,771 +237%
Man Group
59
Man Group
United Kingdom
$3.33M +$1.03M +21,633 +68%
MAP
60
Moody Aldrich Partners
Massachusetts
$3.27M +$50.7K +1,066 +2%
Invesco
61
Invesco
Georgia
$3.23M +$1.34M +28,139 +119%
Two Sigma Investments
62
Two Sigma Investments
New York
$3.1M +$422K +8,874 +22%
Swiss National Bank
63
Swiss National Bank
Switzerland
$2.92M +$57K +1,200 +3%
GPCM
64
Granite Point Capital Management
Massachusetts
$2.61M – – –
EGI
65
EAM Global Investors
California
$2.58M +$1.97M +41,530 New
Victory Capital Management
66
Victory Capital Management
Texas
$2.58M +$296K +6,228 +18%
CM
67
Caption Management
Oklahoma
$2.48M +$1.9M +39,900 New
PPA
68
Parametric Portfolio Associates
Washington
$2.39M +$567K +11,928 +45%
Legal & General Group
69
Legal & General Group
United Kingdom
$2.38M +$1.6M +33,766 +741%
Morgan Stanley
70
Morgan Stanley
New York
$2.38M -$14.4M -302,667 -89%
California Public Employees Retirement System
71
California Public Employees Retirement System
California
$2.25M +$1.31M +27,458 +317%
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$2.22M +$1.57M +33,012 +1,227%
Rafferty Asset Management
73
Rafferty Asset Management
New York
$2.08M -$306K -6,433 -16%
Voloridge Investment Management
74
Voloridge Investment Management
Florida
$2.01M +$172K +3,609 +13%
TD Asset Management
75
TD Asset Management
Ontario, Canada
$1.99M +$1.01M +21,200 +196%
1 2
3
4 5

DCPH Hedge Fund Activity: Q4 2019 in Review

153 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q4 2019, worth a combined $2.22B — up 85% from $1.2B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new DCPH positions and 13 closed out — a net gain of 33 holders — while 63 added to existing stakes and 35 trimmed.

The largest buyer was Franklin Resources, adding an estimated $74.3M. The largest seller was Millennium Management, cutting an estimated $126M.

  • 153 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q4 2019, up from 122 in Q3 2019.
  • Funds reported $2.22B of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q4 2019, up 85% quarter-over-quarter.
  • 46 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q4 2019 and 13 closed out, a net change of +33 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q4 2019 was Franklin Resources, an estimated $74.3M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q4 2019 was Millennium Management, an estimated $126M sold.

Based on aggregated 13F filings for Q4 2019.